{{PBB|geneid=643}}

'''C-X-C趋化因子受体5'''（{{lang-en|'''C-X-C chemokine receptor type 5'''}}，'''CXC-R5'''）也被称为'''CD185'''（[[分化簇|分化簇]]185）或伯基特淋巴瘤受体1（{{lang-en|'''Burkitt lymphoma receptor 1'''}}，'''BLR1'''）是一种[[G蛋白偶联受体|G蛋白偶联的]]七跨膜受体，属于[[CXC趋化因子受体|CXC趋化因子受体]]家族，其配体为趋化因子[[CXCL13|CXCL13]]（也被称为BLC）。在人类中，CXC-R5蛋白质由 ''CXCR5'' [[基因|基因]]编码<ref name="pmid1425907">{{cite journal | author = Dobner T, Wolf I, Emrich T, Lipp M | title = Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma | journal = Eur. J. Immunol. | volume = 22 | issue = 11 | pages = 2795–9 |date=November 1992 | pmid = 1425907 | doi = 10.1002/eji.1830221107 }}</ref>。

== 组织分布与功能 ==

''BLR1'' / ''CXCR5'' [[基因|基因]]特异性表达于[[伯基特淋巴瘤|伯基特淋巴瘤]]以及其它淋巴组织，比如[[淋巴结|淋巴结]]和[[脾脏|脾脏]]中的淋巴滤泡。该基因对[[B细胞|B细胞]]的迁移起到重要作用<ref name="pmid8978608">{{cite journal | author = Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M | title = A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | journal = Cell | volume = 87 | issue = 6 | pages = 1037–47 | year = 1996 | pmid = 8978608 | doi = 10.1016/S0092-8674(00)81798-5 }}</ref>。

==临床意义==

[[T细胞|T细胞]]会表达CD4<sup>+</sup>CXCR5<sup>+</sup>以对抗[[结核杆菌|结核杆菌]]（Mtb）感染<ref name="pmid23281399">{{cite journal | author = Slight SR, Rangel-Moreno J, Gopal R, Lin Y, Fallert Junecko BA, Mehra S, Selman M, Becerril-Villanueva E, Baquera-Heredia J, Pavon L, Kaushal D, Reinhart TA, Randall TD, Khader SA | title = CXCR5+ T helper cells mediate protective immunity against tuberculosis | journal = J. Clin. Invest. | volume = | issue = | pages = |date=January 2013 | pmid = 23281399 | doi = 10.1172/JCI65728 | laysummary = | laysource = | pmc=3561804}}</ref>。

==参考文献==
{{Reflist}}
{{-}}
==延伸阅读==
{{refbegin | 2}}
*{{cite journal  | author=Lipp M, Müller G |title=Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. |journal=Verhandlungen der Deutschen Gesellschaft für Pathologie |volume=87 |issue=  |pages= 90–101 |year= 2006 |pmid= 16888899 |doi=  }}
*{{cite journal  | author=Barella L, Loetscher M, Tobler A, ''et al.'' |title=Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. |journal=Biochem. J. |volume=309 |issue=  3|pages= 773–9 |year= 1995 |pmid= 7639692 |doi=  | pmc=1135699  }}
*{{cite journal  | author=Legler DF, Loetscher M, Roos RS, ''et al.'' |title=B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. |journal=J. Exp. Med. |volume=187 |issue= 4 |pages= 655–60 |year= 1998 |pmid= 9463416 |doi=10.1084/jem.187.4.655  | pmc=2212150  }}
*{{cite journal  | author=Gunn MD, Ngo VN, Ansel KM, ''et al.'' |title=A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. |journal=Nature |volume=391 |issue= 6669 |pages= 799–803 |year= 1998 |pmid= 9486651 |doi= 10.1038/35876 }}
*{{cite journal  | author=Müller G, Lipp M |title=Signal transduction by the chemokine receptor CXCR5: structural requirements for G protein activation analyzed by chimeric CXCR1/CXCR5 molecules. |journal=Biol. Chem. |volume=382 |issue= 9 |pages= 1387–97 |year= 2002 |pmid= 11688722 |doi=10.1515/BC.2001.171  }}
*{{cite journal  | author=Schaerli P, Loetscher P, Moser B |title=Cutting edge: induction of follicular homing precedes effector Th cell development. |journal=J. Immunol. |volume=167 |issue= 11 |pages= 6082–6 |year= 2002 |pmid= 11714765 |doi=  10.4049/jimmunol.167.11.6082}}
*{{cite journal  | author=Kim CH, Johnston B, Butcher EC |title=Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. |journal=Blood |volume=100 |issue= 1 |pages= 11–6 |year= 2002 |pmid= 12070001 |doi= 10.1182/blood-2001-12-0196 }}
*{{cite journal  | author=Carlsen HS, Baekkevold ES, Johansen FE, ''et al.'' |title=B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. | url=https://archive.org/details/sim_gut_2002-09_51_3/page/364 |journal=Gut |volume=51 |issue= 3 |pages= 364–71 |year= 2002 |pmid= 12171958 |doi=10.1136/gut.51.3.364  | pmc=1773345  }}
*{{cite journal  | author=Battle TE, Yen A |title=Ectopic expression of CXCR5/BLR1 accelerates retinoic acid- and vitamin D(3)-induced monocytic differentiation of U937 cells. |journal=Exp. Biol. Med. (Maywood) |volume=227 |issue= 9 |pages= 753–62 |year= 2002 |pmid= 12324654 |doi=  }}
*{{cite journal  | author=Lisignoli G, Toneguzzi S, Piacentini A, ''et al.'' |title=Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release. |journal=J. Cell. Physiol. |volume=194 |issue= 1 |pages= 71–9 |year= 2003 |pmid= 12447991 |doi= 10.1002/jcp.10188 }}
*{{cite journal  | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899  | pmc=139241 }}
*{{cite journal  | author=Chan CC, Shen D, Hackett JJ, ''et al.'' |title=Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. | url=https://archive.org/details/sim_ophthalmology_2003-02_110_2/page/421 |journal=Ophthalmology |volume=110 |issue= 2 |pages= 421–6 |year= 2003 |pmid= 12578791 |doi= 10.1016/S0161-6420(02)01737-2 }}
*{{cite journal  | author=Flynn G, Maru S, Loughlin J, ''et al.'' |title=Regulation of chemokine receptor expression in human microglia and astrocytes. |journal=J. Neuroimmunol. |volume=136 |issue= 1-2 |pages= 84–93 |year= 2003 |pmid= 12620646 |doi=10.1016/S0165-5728(03)00009-2  }}
*{{cite journal  | author=Lisignoli G, Piacentini A, Toneguzzi S, ''et al.'' |title=Age-associated changes in functional response to CXCR3 and CXCR5 chemokine receptors in human osteoblasts. |journal=Biogerontology |volume=4 |issue= 5 |pages= 309–17 |year= 2004 |pmid= 14618028 |doi=10.1023/A:1026203502385  }}
*{{cite journal  | author=Aust G, Sittig D, Becherer L, ''et al.'' |title=The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. |journal=Eur. J. Endocrinol. |volume=150 |issue= 2 |pages= 225–34 |year= 2004 |pmid= 14763921 |doi=10.1530/eje.0.1500225  }}
*{{cite journal  | author=Howard OM, Dong HF, Su SB, ''et al.'' |title=Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate. |journal=Blood |volume=105 |issue= 11 |pages= 4207–14 |year= 2005 |pmid= 15713799 |doi= 10.1182/blood-2004-07-2697  | pmc=1895027 }}
*{{cite journal  | author=Steinmetz OM, Panzer U, Kneissler U, ''et al.'' |title=BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. | url=https://archive.org/details/sim_kidney-international_2005-04_67_4/page/1616 |journal=Kidney Int. |volume=67 |issue= 4 |pages= 1616–21 |year= 2005 |pmid= 15780119 |doi= 10.1111/j.1523-1755.2005.00244.x }}
*{{cite journal  | author=Hu C, Xiong J, Zhang L, ''et al.'' |title=PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia. |journal=Cell. Mol. Immunol. |volume=1 |issue= 4 |pages= 280–94 |year= 2006 |pmid= 16225771 |doi=  }}
{{refend}}


{{细胞因子受体}}
{{Clusters of differentiation}}
{{G protein-coupled receptors}}
[[Category:分化群|Category:分化群]]